Insider Selling: 111 (NASDAQ:YI) Director Sells $25,553.00 in Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jian David Sun sold 111,100 shares of the stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $0.23, for a total value of $25,553.00. Following the transaction, the director directly owned 472,011 shares of the company’s stock, valued at $108,562.53. The trade was a 19.05% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jian David Sun also recently made the following trade(s):

• On Wednesday, June 10th, Jian David Sun sold 115,440 shares of 111 stock. The shares were sold at an average price of $0.22, for a total value of $25,396.80.
• On Tuesday, June 9th, Jian David Sun sold 12,000 shares of 111 stock. The shares were sold at an average price of $0.23, for a total value of $2,760.00.
• On Wednesday, May 27th, Jian David Sun sold 70,440 shares of 111 stock. The shares were sold at an average price of $0.25, for a total value of $17,610.00.
• On Tuesday, May 26th, Jian David Sun sold 29,280 shares of 111 stock. The shares were sold at an average price of $0.27, for a total value of $7,905.60.

111 Stock Performance

NASDAQ:YI opened at $4.89 on Monday. 111, Inc. Sponsored ADR has a one year low of $2.48 and a one year high of $11.17. The stock has a market cap of $42.98 million, a PE ratio of -3.49 and a beta of 0.60. The stock has a 50 day moving average price of $5.92 and a 200 day moving average price of $5.66.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings cut 111 from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 4th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.